Drug-related infectious diseases indicator

EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; I. GIRAUDON ; L. WIESSING ; E. KALAMARA ; D. HEDRICH ; R. SIMON ; K. PALCZAK ; J. VICENTE | 2015
Document texte divers

Drug-related infectious diseases (DRID) are among the most serious health consequences of drug use. The DRID indicator collects data on the extent of drug-related infections among people who inject drugs. This group is a key population affected [...]

Plus d'info

Ajouter à la sélection

Lien externe

Document numérique

Hepatitis C among drug users in Europe. Epidemiology, treatment and prevention

OEDT = EMCDDA ; M. HICKMAN, Éditeur scientifique ; N. K. MARTIN, Éditeur scientifique ; I. GIRAUDON ; L. WIESSING ; D. HEDRICH ; E. KALAMARA ; P. GRIFFITHS ; R. SIMON | 2016
Rapport

FRANÇAIS : L'hépatite C est une maladie infectieuse du foie causée par le virus de l'hépatite C (VHC) qui peut être transmis par le sang. Environ 115 millions de personnes à travers le monde ont été infectées à un moment donné de leur vie par l[...]

Plus d'info

Ajouter à la sélection

Lien externe

Documents numériques

Human immunodeficiency virus among people who inject drugs: Is risk increasing in Europe?

D. HEDRICH ; E. KALAMARA ; O. SFETCU ; A. PHARRIS ; A. NOOR ; L. WIESSING ; V. HOPE ; M. J. VAN DE LAAR | 2013
Dans Eurosurveillance (Vol.18, n°48, 28 November 2013) Article : Périodique

In most European Union (EU)/European Economic Area (EEA) countries, between 2010 and 2012, reports of new human immunodeficiency virus (HIV) diagnoses among people who inject drugs have been stable or declining. HIV outbreaks in Greece and Roman[...]

Plus d'info

Ajouter à la sélection

Lien externe

Monitoring drug use in the digital age: studies in web surveys Quantitative and qualitative assessments of data quality within the European Web Survey on Drugs

E. KALAMARA ; K. SKARUPOVA | 2022
Rapport

This paper assesses data quality in the first two rounds of the European Web Survey on Drugs (EWSD). Data quality has various dimensions, such as accuracy, consistency, validity and completeness, but can be defined as fitness of the data for the[...]

Plus d'info

Ajouter à la sélection

Lien externe

Document numérique

Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study

L. WIESSING ; M. FERRI ; V. BELACKOVA ; P. CARRIERI ; S. R. FRIEDMAN ; C. FOLCH ; K. DOLAN ; B. GALVIN ; P. VICKERMAN ; J. V. LAZARUS ; V. MRAVCIK ; M. KRETZSCHMAR ; V. SYPSA ; A. SARASA-RENEDO ; A. UUSKULA ; D. PARASKEVIS ; L. MENDAO ; D. ROSSI ; N. VAN GELDER ; L. MITCHESON ; L. PAOLI ; C. DIAZ GOMEZ ; M. MILHET ; N. DASCALU ; J. KNIGHT ; G. HAY ; E. KALAMARA ; R. SIMON ; C. M. COMISKEY ; C. ROSSI ; P. GRIFFITHS ; EUBEST working group | 2017
Dans Harm Reduction Journal (Vol.14, n°19, 2017) Article : Périodique

Background and aims: Despite advances in our knowledge of effective services for people who use drugs over the last decades globally, coverage remains poor in most countries, while quality is often unknown. This paper aims to discuss the histori[...]

Plus d'info

Ajouter à la sélection

Lien externe

Problem drug use indicator

EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; D. THANKI ; E. KALAMARA ; A. NOOR ; L. MONTANARI ; J. VICENTE | 2015
Document texte divers

Some drug users go on to develop more severe forms of use, defined by the EMCDDA as 'high-risk drug use': 'recurrent drug use that is causing actual harms (negative consequences) to the person (including dependence, but also other health, psycho[...]

Plus d'info

Ajouter à la sélection

Lien externe

Document numérique

The use of multi-national web surveys for comparative analysis: Lessons from the European Web Survey on Drugs

J. MATIAS ; E. KALAMARA ; F. MATHIS ; K. SKARUPOVA ; A. NOOR ; N. SINGLETON | 2019
Dans International Journal of Drug Policy (Vol.73, November 2019) Article : Périodique

Background: Most comparative drug policy analyses utilise measures of drug use, often from general population surveys (GPS). However, the limitations of GPS are well-recognised, including the small numbers of people who use illicit drugs sampled[...]

Plus d'info

Ajouter à la sélection

Univariable associations between a history of incarceration and HIV and HCV prevalence among people who inject drugs across 17 countries in Europe 2006 to 2020 - is the precautionary principle applicable?

L. WIESSING ; E. KALAMARA ; J. STONE ; P. ALTAN ; L. VAN BAELEN ; A. FOTIOU ; D. GARCIA ; J. GOULAO ; B. GUARITA ; V. HOPE ; M. JAUFFRET-ROUSTIDE ; L. JURGELAITIENE ; M. KABERG ; A. KAMARULZAMAN ; L. LEMSALU ; A. KIVITE-URTANE ; B. KOLARIC ; L. MONTANARI ; M. ROSINSKA ; L. SAVA ; I. HORVATH ; T. SEYLER ; V. SYPSA ; A. TARJAN ; I. YIASEMI ; R. ZIMMERMANN ; M. FERRI ; K. DOLAN ; A. UUSKULA ; P. VICKERMAN | 2021
Dans Eurosurveillance (Vol.26, n°49, 09 Decembe 2021) Article : Périodique

Background: People who inject drugs (PWID) are frequently incarcerated, which is associated with multiple negative health outcomes. Aim: We aimed to estimate the associations between a history of incarceration and prevalence of HIV and HCV infe[...]

Plus d'info

Ajouter à la sélection

Lien externe